Product ID: SQMIG35H2039
Global Recombinant Protein Market Size, Share, Growth Analysis, By Product Type(Hormone, Enzymes), By Application(Research, Therapeutics) - Industry Forecast 2024-2031
Report ID:
SQMIG35H2039 |
Region:
Global |
Published Date: February, 2024
Pages:
165
|
Tables:
66 |
Figures:
75
Global Recombinant Protein Market Dynamics
Driver
Increasing demand for Biopharmaceuticals and R&D investment to fuel the recombinant protein market.
- The market has seen a consistent increase in R&D expenditure and funding in pharmaceutical and biotechnological firms throughout the period. The number of regulatory requirements has increased dramatically in recent years, expanding a lot of choices to those with unusual illnesses like hemophilia and other bleeding disorders.
- The growing demand for biopharmaceuticals comprising recombinant proteins is growing due to their high potency, specificity, and lower side effects as compared with traditional small molecule drugs. Following, as a result, recombinant protein drugs are developed for a wide range of diseases including autoimmune disorders, infectious diseases, and cancer.
Restraint
Decreasing cost of recombinant protein and lack of professionals to limit the market growth.
- When a large number of key players enter a limited market and offer comparative products, price competition occurs. In these conditions, the cost of such items appears to be gradually lowering, limiting the expansion of the recombinant protein market.
- The shortage of trained medical specialists in the field of recombinant proteins also stifles industrial progress.
Global Recombinant Protein Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 351-333-4748
